Gaas, Marcial G.
HRN: 19-12-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/13/2023
05/21/2023
IV
300mg
QID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes